Maternal and Neonatal Outcomes of Gestational Thrombocytopenia in Pregnant Women from Kirkuk City, Iraq: A Case-Control Study

Esraa Abdulkareem Mohammed; Mohammed Fatih Haseeb

doi:10.54133/ajms.v5i1S.324

Authors

Esraa Abdulkareem Mohammed Department of Gynecology and Obstetrics, College of Medicine, University of Kirkuk, Kirkuk, Iraq https://orcid.org/0000-0002-8425-6040
Mohammed Fatih Haseeb Department of Pathology/Hematology, College of Medicine, University of Kirkuk, Kirkuk, Iraq

DOI:

https://doi.org/10.54133/ajms.v5i1S.324

Keywords:

Maternal outcomes, Neonatal outcomes, Pregnant women, Thrombocytopenia

Abstract

Background: Thrombocytopenia is the most common hematological disorder in pregnant women, second only to anemia. A platelet count of less than 150x10⁹/L is regarded as low. It is the most common cause of thrombocytopenia during pregnancy when the platelet count does not fall below 70x10⁹\L. Methods: A case-control study was carried out in the department of obstetrics and gynecology at Azadi Teaching Hospital, Kirkuk, Iraq. Two hundred pregnant women were enrolled in the study; they were divided into 100 cases and 100 controls. All participants were in labor at the time of admission. The cases were pregnant women with gestational thrombocytopenia, while the controls were pregnant women with a normal platelet count. A platelet count was performed for all participants using the Swelab Alfa Plus system. Results: mean gestational age and platelet count were significantly lower in patients than controls, while there was no statistically significant difference in age or parity between the study groups. Preterm labor, postpartum hemorrhage (PPH), intrauterine fetal growth restriction (IUGR), and intrapartum fetal distress were significantly higher in the patients than in the controls, and the mean APGAR score at 5 minutes was significantly lower in the patients compared to the controls. Conclusions: Pregnant women with gestational thrombocytopenia may be at higher risk of preterm labor, postpartum hemorrhage, IUGR, intrapartum fetal distress and a low neonatal APGAR score.

Downloads

References

Ali Khalaf M, Khider DM, Kamal BJ. Anemia in pregnant women in Kirkuk Governorate. Kirkuk J Med Sci. 2020;8(1):78-85. doi: 10.32894/kjms.2020.169358. DOI: https://doi.org/10.32894/kjms.2020.169358

McCrae KR. Thrombocytopenia in pregnancy. Hematology Am Soc Hematol Educ Program. 2010;2010(1):397-402. doi: 10.1182/asheducation-2010.1.397. DOI: https://doi.org/10.1182/asheducation-2010.1.397

Park YH. Diagnosis and management of thrombocytopenia in pregnancy. Blood Res. 2022;57(S1):79-85. doi: 10.5045/br.2022.2022068. DOI: https://doi.org/10.5045/br.2022.2022068

Shehata N, Burrows R, Kelton JG. Gestational thrombocytopenia. Clin Obstet Gynecol. 1999;42(2):327-334. doi:10.1097/00003081-199906000-00017. DOI: https://doi.org/10.1097/00003081-199906000-00017

Jayawardena L, Mcnamara E. Diagnosis and management of pregnancies complicated by haemolysis, elevated liver enzymes and low platelets syndrome in the tertiary setting. Int Med J. 2020;50(3):342-349. doi: 10.1111/imj.14337. DOI: https://doi.org/10.1111/imj.14337

Subtil SFC, Mendes JMB, Areia ALFA, Moura JPAS. Update on thrombocytopenia in pregnancy. Rev Bras Ginecol Obstet. 2020;42(12):834-840. doi: 10.1055/s-0040-1721350. DOI: https://doi.org/10.1055/s-0040-1721350

Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med. 1993;329(20):1463-1466. doi:10.1056/NEJM199311113292005. DOI: https://doi.org/10.1056/NEJM199311113292005

Perepu U, Rosenstein L. Maternal thrombocytopenia in pregnancy. Proc Obstet Gynecol. 2013;3(1): 1-15. Available from: http://ir.uiowa.edu/pog/ DOI: https://doi.org/10.17077/2154-4751.1193

Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, et al. Platelet counts during pregnancy. N Engl J Med. 2018;379(1):32-43. doi:10.1056/NEJMoa1802897. DOI: https://doi.org/10.1056/NEJMoa1802897

Mohammed EA. Postpartum maternal and neonatal outcomes of SARS-CoV-2 infection during pregnancy. Al-Rafidain J Med Sci. 2023;5: 67-72. doi: 10.54133/ajms.v5i.159 DOI: https://doi.org/10.54133/ajms.v5i.159

Nathan N, Sol I, Vincelot A, Collet D, Granchamp P, David E. Is a biological assessment necessary to realize an obstetrical epidural anaesthesia in a patient whose interrogation and clinical examination are strictly normal? Ann Fr Anesth Reanim. 2007;26(7-8):705-710. doi: 10.1016/j.annfar.2007.05.007. DOI: https://doi.org/10.1016/j.annfar.2007.05.007

Elveđi-Gašparović V, Beljan P, Gverić-Ahmetašević S, Schuster S, Škrablin S. Fetal-maternal complications and their association with gestational thrombocytopenia. Ginekol Pol. 2016;87(6):454-459. doi:10.5603/GP.2016.0025. DOI: https://doi.org/10.5603/GP.2016.0025

Kim BJ, Kim HS, Kim JH, Lee KY. Moderate to severe thrombocytopenia during pregnancy: A Single Institutional Experience. Indian J Hematol Blood Transfus. 2017;33(4):581-585. doi: 10.1007/s12288-017-0784-1. DOI: https://doi.org/10.1007/s12288-017-0784-1

Muhammad EM, Sabri EH, Saeed HD. The prevalence of thrombocytopenia in pregnant women in Baghdad: single centre study. J Fac Med Baghdad. 2018;60(2):98-101. doi: 10.32007/jfacmedbagdad.60213. DOI: https://doi.org/10.32007/jfacmedbagdad.60213

Gernsheimer T, James AH, Stasi R. How I treat thrombocytopenia in pregnancy. Blood. 2013;121(1):38-47. doi: 10.1182/blood-2012-08-448944. DOI: https://doi.org/10.1182/blood-2012-08-448944

Cines DB, Levine LD. Thrombocytopenia in pregnancy. Hematology Am Soc Hematol Educ Program. 2017;2017(1):144-151. doi: 10.1182/asheducation-2017.1.144. DOI: https://doi.org/10.1182/asheducation-2017.1.144

Habas ES, Rayani A, Alfitori G, Eldin Ahmed G, Elzouki AY. Gestational thrombocytopenia: A Review on recent updates. Cureus. 2022;14(3):e23204. doi: 10.7759/cureus.23204. DOI: https://doi.org/10.7759/cureus.23204

Borhany M, Abid M, Zafar S, Zaidi U, Munzir S, Shamsi T. Thrombocytopenia in pregnancy: Identification and management at a reference center in Pakistan. Cureus. 2022;14(3). doi: 10.7759/cureus.23490. DOI: https://doi.org/10.7759/cureus.23490

Yousif A. The significance of asymptomatic gestational thrombocytopenia. Med J Tikrit University. 2017;22(1):96-102.

Zutshi V, Gupta N, Arora R, Dhanker S. Prevalence of gestational thrombocytopenia and its effect on maternal and fetal outcome. Iraqi J Hematol. 2019;8:21-24. doi: 10.4103/ijh.ijh_17_18. DOI: https://doi.org/10.4103/ijh.ijh_17_18

Taş B, Günenc O. Maternal and fetal outcomes of gestational thrombocytopenia. Duzce Med J. 2022; 24(3): 282-286. doi: 10.18678/dtfd.1162645. DOI: https://doi.org/10.18678/dtfd.1162645

Nagey DA, Alger LS, Edelman BB, Heyman MR, Pupkin MJ, Crenshaw C. Reacting appropriately to thrombocytopenia in pregnancy. South Med J. 1986;79(11):1385-1388. doi: 10.1097/00007611-198611000-00017. DOI: https://doi.org/10.1097/00007611-198611000-00017

Ciobanu AM, Colibaba S, Cimpoca B, Peltecu G, Panaitescu AM. Thrombocytopenia in pregnancy. Maedica (Bucur). 2016;11(1):55-60. PMID: 28465752.